From MarketBeat:

VanEck Pharmaceutical ETF (PPH) declared a dividend of 0.3074 per share, with an ex-dividend date of December 27th. The stock of PPH traded at $81.13, with a 12-month low of $73.40 and a 12-month high of $83.35. The company has a market capitalization of $412.95 million, a price-to-earnings ratio of 16.59, and a beta of 0.72.

Institutional investors have recently modified their holdings of PPH, including Northwestern Mutual Wealth Management Co., JPMorgan Chase & Co., Comerica Bank, Citigroup Inc., and Cetera Advisor Networks LLC.

VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund based on the MVIS US Listed Pharmaceutical 25 index, managed by VanEck. The company was launched on Feb 1, 2000. An instant news alert was provided by narrative science technology and financial data from MarketBeat.

The article also includes links to the five stocks that top-rated analysts are recommending and a free report on seven promising stocks for long-term outlooks.



Read more: VanEck Pharmaceutical ETF Announces Dividend of $0.31 (NASDAQ:PPH)